Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Submit for the Fierce Pharma Marketing Awards - Deadline ends this Friday, July 3rd
Type 1 diabetes
Pharma
After 2-month delay, Sanofi gains FDA expansion for Tzield
Sanofi has scored an FDA expansion for its Type 1 diabetes treatment Tzield. The decision came nearly two months after its original target date.
Kevin Dunleavy
Jun 15, 2026 11:25am
Sanofi asks out of FDA's CNPV program for Tzield expansion: Stat
May 6, 2026 4:00pm
GenEdit rebrands as BreezeBio, raises $60M for genetic drug R&D
Feb 25, 2026 7:00am
Medtronic MiniMed campaign pushes people with T1D to 'Own It'
Dec 18, 2025 12:05pm
Sanofi expands price cut to $35 monthly for all insulin products
Sep 26, 2025 1:00pm
Europe's CHMP gives nods to Novo's Kyinsu, Bayer's Lynkuet
Sep 19, 2025 10:45am
